| Financial Year |
March 31 2023 |
| Monetary Funds |
11,428,270,376.40 |
| Held-for-trading Financial Assets |
206,373.13 |
| Notes Receivable |
-- |
| Accounts Receivable |
249,513,038.24 |
| Advances to Suppliers |
76,750,325.03 |
| Other Receivables |
2,179,118,191.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
30,000,000.00 |
| Inventories |
18,996,708,342.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
878,150,928.58 |
| Total Current Assets |
33,828,433,893.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,979,520.40 |
| Long-term Equity Investment |
19,681,132,033.00 |
| Investment Properties |
2,350,062,364.54 |
| Fixed Assetes |
8,891,181,861.27 |
| Under-construction Projects |
789,444,174.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
328,332,727.14 |
| R&D expenses |
-- |
| Goodwill |
43,415,543.91 |
| Long-Term Deferred and Prepaid Expenses |
20,814,721.37 |
| Deferred Income Tax Assets |
481,458,715.71 |
| Other Non-Current Assets |
35,214,072.82 |
| Sub-Total of Non-Current Assets |
46,077,339,967.79 |
| Total Assets |
79,905,773,861.12 |
| Short-Term Loans |
13,323,279,451.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,649,078.72 |
| Accounts Payable |
994,178,057.04 |
| Accounts Received In Advance |
9,132,825.52 |
| Employee Compensation Payable |
137,808,202.50 |
| Taxes Payable |
1,579,705,401.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,911,404,779.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,056,633,935.00 |
| Other Current Liabilities |
755,177,942.41 |
| Sub-Total of Current Liabilities |
33,071,469,984.97 |
| Long-term Loans |
6,060,374,937.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
34,601,144.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
656,876,272.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,066,911,768.16 |
| Total Liabilities |
40,138,381,753.13 |
| Paid-In Capital(Or Share Stock) |
4,628,902,973.00 |
| Capital Surplus |
1,551,749,237.93 |
| Surplus Reserve |
2,834,566,584.80 |
| LESS:Treasury Stock |
288,797,462.46 |
| Undistributed Profits |
33,676,226,294.05 |
| Minority Stockholder's Interest |
238,598,384.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,528,793,723.79 |
| Owner's Equity（Stockholder's Equity） |
39,767,392,107.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
79,905,773,861.12 |
